Patient still fatigued, labs normal? Assess sleep

The third follow-up, and the panel you are about to order

You have done the careful version of this workup. Thyroid with antibodies, iron studies, B12, morning cortisol, inflammatory markers. Diet, movement and supplements addressed. All unremarkable.

And she is in front of you at the third follow-up saying she sleeps seven and a half hours and still feels like she has been hit by a truck.

Most of us reach for a deeper panel here, because ordering something is the only next step we have language for.

There is another one. When a patient is still fatigued and labs are normal, the workup has asked one question about sleep, which is how many hours, then moved on to serum. In this patient, hours are the one sleep variable you already know is adequate.

Why sleep duration is necessary but not sufficient

Duration is not irrelevant. In a 2026 study recording portable EEG across a week of ordinary work nights, longer objective total sleep time independently predicted less morning sleepiness (Kawai et al., 2026). Hours matter.

The same study found other parameters carrying weight. Longer objective sleep onset latency, the time it takes to fall asleep after lights out, predicted less restorative sleep, and a higher percentage of deep sleep independently reduced morning sleepiness. Both sat alongside total sleep time, not instead of it.

So duration is necessary but not sufficient. Continuity, latency, timing regularity and slow-wave depth carry variance that hours alone do not, and hours are the only sleep variable the workup asked about.

What a fragmented night does to the deepest sleep

Cortical micro-arousals are brief shifts in EEG activity, a few seconds long, that interrupt sleep without any memory of waking. The patient does not report them. A wearable does not subtract them from total sleep time. They still truncate slow-wave bouts and force the stage transitions that fragmentation indices track (Thomas, 2024).

That matters, because deep sleep is front-loaded. A cycle runs roughly 90 to 110 minutes, and as the night progresses REM lengthens while time in deep NREM sleep declines (Patel et al., n.d.). So a night that keeps breaking in the first two cycles preferentially costs slow-wave sleep, the window fragmentation research links to loss of the nocturnal blood pressure dip (Thomas, 2024).

Your patient banks the time in bed. She does not bank the depth. If she is also perimenopausal, that fragmentation has its own drivers, set out in our guide to behavioral sleep support for menopausal patients.

What the evidence actually says about sleep quality and fatigue

A 2024 commentary in Sleep sets out the usable metrics: sleep efficiency, arousal index, number of awakenings, stage transitions, cyclic alternating pattern and spindle density (Thomas, 2024). It is a commentary, not a trial, so treat it as a framework rather than evidence of effect. Its argument is that fragmentation has been underweighted next to hypoxia, and tracks with daytime sleepiness, glucose dysregulation, inflammation and loss of nocturnal blood pressure dipping.

The pattern point has harder support. Across 60,977 UK Biobank adults wearing wrist accelerometers, sleep regularity predicted all-cause mortality better than duration did: a hazard ratio of 0.70 for the most regular fifth against the least, compared with 0.76 for duration (Windred et al., 2024).

So the shape of the night carries information the hours do not, which is why a patient can be still fatigued when labs are normal and every sleep number looks fine.

The 2026 primary care data on treating fatigue behaviorally

A 2026 feasibility study in Swedish primary care enrolled this exact presentation: adults with severe, functionally disabling fatigue of at least three months, not explained by an active disease process.

Eighteen enrolled, fourteen completed. The intervention was blended transdiagnostic CBT, around ten face-to-face sessions plus internet modules, targeting perpetuating factors including a disrupted sleep-wake cycle, unhelpful beliefs about fatigue, and uneven activity. Fatigue severity fell a mean 13.34 points on the CIS-F, a within-group Cohen's d of 1.35, and six of eighteen scored below 35 afterward (Svärdman et al., 2026).

State the limit plainly: single-arm, small sample, no control group. It shows the approach is deliverable in primary care. Efficacy still needs a controlled trial.

A five-minute sleep continuity assessment for a normal visit

You do not need a sleep study for most of this. When a patient is still fatigued and labs are normal, you need better questions than "how many hours."

1. 01

   Time in bed versus time asleep

   "When do lights go out, when do you get up, and how much of that are you actually asleep?" The ratio is a bedside proxy for sleep efficiency. Below roughly 85 percent is the threshold commonly used to act on.

2. 02

   Sleep onset latency

   "How long from lights out to asleep?" Longer latency predicted less restorative sleep in the EEG data above.

3. 03

   Night breaks

   "How many times do you surface, and how long are you awake?" You want wake after sleep onset, not just whether she remembers waking.

4. 04

   Timing regularity

   "What time did you go to bed and get up each of the last seven nights?" Variance is the signal, and it is usually wider than she assumes.

5. 05

   The first three hours

   "Is the early part of the night solid, or is that when you are restless?" Early fragmentation is the expensive kind.

6. 06

   Confounder screen

   Screen for depressive symptoms, which independently raised morning sleepiness in every model of that same study (Kawai et al., 2026). Record them and repeat next visit. Two data points make this an outcome measure rather than an anecdote, which is where the work of improving patient adherence between visits begins.

What not to do when a fatigue workup comes back normal

Do not order the fifth panel simply to have ordered something. It buys six weeks, returns the same answer, and repeated testing without explanation erodes trust. That is the same pattern described in why good treatment plans fail between visits.

Do not reassure her that her sleep is fine because she gets seven and a half hours. She will hear it as dismissal.

Do not deliver the plan as a printed handout and hope. Sound clinical reasoning dies there more often than anywhere else, which is most of why patients don't follow treatment plans.

The uncomfortable part most practices skip

Assessment is the easy half. What moves sleep continuity, a consistent wake time, a real wind-down, stimulus control, and giving up the weekend lie-in, is simple to describe and hard to sustain alone. These changes fail in the hundreds of unsupported hours between visits, not in the room with you.

That is a delivery problem, not a willpower problem, and delivery is staffable. At Clementine we run an embedded coaching service line inside practices, the between-visit behavioral support layer that carries the sleep plan while the patient stays yours. For its operational shape, what telehealth behavioral support looks like in practice walks through the model.

When to refer instead of coach

Refer, do not coach

Behavioral sleep support complements medical management. It does not replace it, and it is not the right first move for every patient still fatigued when labs are normal. Refer to sleep medicine rather than coaching when you hear:

• Witnessed apneas or gasping, or loud snoring with elevated BMI or neck circumference
• An urge to move the legs at rest that eases with movement and worsens at night
• Profound post-exertional malaise after ordinary activity
• Sleepiness at the wheel, or falling asleep in passive situations by day
• Sudden loss of muscle tone with emotion, or abrupt sleep attacks
• Those are diagnostic questions for a sleep physician. The assessment above is a triage tool, and nothing here is medical advice for an individual patient.

Where this leaves the patient in your chair

When your patient is still fatigued and labs are normal, you are not out of options. You have been measuring the wrong sleep variable.

The next visit does not need a new panel. It needs six questions, a written baseline, and a decision about who supports the change.

For the wider picture of which patient outcomes move when sleep continuity improves, start here.